We found that, compared to vehicle-treated cells, both infection with IAV and treatment with MG132 inhibited the degradation of ubiquitin-conjugated BIK at 24 (Fig. 5E) and 48 hpi (SI Appendix, Fig. S6D). The gene discussed is BIK; the disease is infection.